INDICAL is a leading solution provider for diagnostic workflows, the protocols for their use, and the support that empowers our customers every day. Our customers play a central role in protecting the health of animals and humans worldwide – that is why nothing matters more to us than improving your ability to do so.
Our mission:
Improving diagnostics
for better animal and
human health together
For decades we have been passionately serving and working closely with private and state diagnostic laboratories to drive innovation that raises standards – ensuring you can produce reliable results today, and have certainty for the future.
Today, INDICAL is an independent company with renewed focus and ambition to pursue our mission with even greater impact.
Heritage
Our story began in 1996, when Labor Diagnostik Leipzig (LDL) was founded as a service laboratory for Vets. Since then, we have established ourselves as an innovative and reliable company, focused on working with and supporting our customers to improve diagnostics.
Global Presence
In addition to growing our teams globally, we develop strong partnerships with local distributors in the countries we serve, to get as close to our customers as possible – so we can improve diagnostics together, no matter where you are located.
- Local presence in 169 countries
- Direct presence in 22 countries
- 75+ Commercial Partners actively distributing our products in 147 countries
Team
Dr. Fredrik Ullman
CEO, VIMIAN Group
Board of Directors
INDICAL’s Board of Directors (through holding company Indical TopCo Ab) is responsible for providing guidance to the CEO and Senior Management, overseeing the company strategy and performance by focusing on serving its customers, growing shareholder value, and corporate governance.
Paul Hökfelt
Chairman of the Board,
INDICAL BIOSCIENCE
Paul Hökfelt is also chairman of The Binding Site and AniCura. He is a senior advisor to the Nordic Capital Funds and the founder of Avance Consulting. Following a career in international finance, Paul has been active in the healthcare sector for over 20 years. From 2007 to 2017, Paul spent nearly 10 years as executive chairman of Unilabs. Prior to that, he was president and CEO of the Capio Group. He was also chairman of the board of Clinique La Colline in Geneva. Paul holds a BA from the Stockholm School of Economics.
Gabriel Fitzgerald
Member of the Board,
INDICAL BIOSCIENCE
Gabriel Fitzgerald is the founder of renowned Swedish investment company Fidelio Capital, which he has headed as CEO since 2010. In addition, he is on the boards of Lyko, AniCura and NN07. He previously spent five years at Nordic Capital following a two-year stint in M&A at Carnegie in Stockholm. Gabriel holds an MSc in Finance from the Stockholm School of Economics as well as a medical degree from Linköping University.
Jacob Wiström
Member of the Board,
INDICAL BIOSCIENCE
Jacob Wiström joined Fidelio Capital in 2013 as an investment manager. He has previous experience of M&A and equity capital markets from the corporate finance department of Svenska Handelsbanken. Jacob is also on the board of Greenfood. Jacob holds an BSc in finance and accounting from the Stockholm School of Economics.
Sven Holmlund
Member of the Board,
INDICAL BIOSCIENCE
Sven Holmlund is the chairman of phenotyping specialist LemnaTec, Germany and medical device company Astrego Diagnostics. Previously, he spent 16 years as CEO of Perten Instruments Group, a global supplier of advanced analytical instruments for quality control in the food and agricultural industries. Sven holds a degree in Mechanical Engineering and an MBA.
Helge Lubenow
Member of the Board,
INDICAL BIOSCIENCE
Helge Lubenow held various senior management positions at Qiagen between 1997 and 2015, including senior vice president and head of molecular diagnostic business. She also handled the integration of firms acquired by Qiagen, including Corbett Life Science, Australia, and Digene Inc., USA. In 2016, she founded AGOS Consulting and additionally joined the Supervisory Board of ProteoMediX AG. Helge has a doctorate in genetics from the University of Cologne and the Max Planck Institute for Plant Breeding Research, Cologne.
Research & Development
For over two decades, our expert team of biologists, biochemists, vets, biotechnologists and technical assistants has redefined reliability within diagnostic testing. We use well established techniques to increase test accuracy, improve workflow efficiency, and ensure supply in times of need – so our customers can produce reliable results today, and have certainty for the future.
We operate to the highest quality standards
INDICAL utilizes well established biochemical, immunological and molecular biology techniques, in addition to:
- World-class S1 and S2 approved laboratories.
- Certification to handle pathogens in accordance with the German Infectious Disease Control Act and the Animal Pathogen Ordinance, with S1 approval for genetic engineering work.
- Operations meeting GLP guidelines.
- Processes certified according to DIN EN ISO 9001:2015.
Technical capacities
Molecular biology lab
- PCR and real-time PCR
- Recombinant technologies
- Standard nucleic acid methods
- Extraction methods
Protein lab
- Protein expression and purification
- Mid-scale bacterial cultivation
- Biochemical and protein analytical methods
Immunological lab
- ELISA, western blot and other standard immunological technologies
- Antibody purification and modification
